BBC · Virtus Biotech Clinical Trials Etf ETF
ETFis Series Trust I
$53.71
+0.60%
At close · Sep 4
Net assets $37,334,487
Holdings115
1 month
+2.27%
Year to date
+39.29%
52-week range
$23.69–$56.18
30-session avg volume
15,990
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000047353
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| ERASCA INC | ERAS | $816,514 | 2.19% |
| ENLIVEN THERAPEUTICS INC | ELVN | $674,935 | 1.81% |
| TANGO THERAPEUTICS INC | TNGX | $638,179 | 1.71% |
| ORUKA THERAPEUTICS INC | ORKA | $625,473 | 1.68% |
| SPYRE THERAPEUTICS INC | SYRE | $611,086 | 1.64% |
| ALUMIS INC | ALMS | $593,054 | 1.59% |
| DIANTHUS THERAPEUTICS INC | DNTH | $575,178 | 1.54% |
| KODIAK SCIENCES INC | KOD | $503,977 | 1.35% |
| REVOLUTION MEDICINES INC | RVMD | $503,844 | 1.35% |
| CORVUS PHARMACEUTICALS INC | CRVS | $500,905 | 1.34% |
| REZOLUTE INC | RZLT | $490,682 | 1.31% |
| DEFINIUM THERAPEUTICS INC | DFTX | $481,207 | 1.29% |
| CG ONCOLOGY INC | CGON | $449,894 | 1.21% |
| JADE BIOSCIENCES INC | JBIO | $449,570 | 1.20% |
| INHIBRX BIOSCIENCES INC | INBX | $447,971 | 1.20% |
| RELAY THERAPEUTICS INC | RLAY | $445,448 | 1.19% |
| NEKTAR THERAPEUTICS | NKTR | $429,027 | 1.15% |
| TYRA BIOSCIENCES INC | TYRA | $423,811 | 1.14% |
| VIR BIOTECHNOLOGY INC | VIR | $421,430 | 1.13% |
| INTELLIA THERAPEUTICS INC | NTLA | $412,475 | 1.10% |
| CENTESSA PHARMACEUTICALS PLC | CNTA | $410,402 | 1.10% |
| ANAPTYSBIO INC | ANAB | $403,516 | 1.08% |
| OMEROS CORP | OMER | $397,003 | 1.06% |
| TECTONIC THERAPEUTIC INC | TECX | $390,629 | 1.05% |
| ALLOGENE THERAPEUTICS INC | ALLO | $389,338 | 1.04% |
| COMPASS PATHWAYS PLC | CMPS | $371,007 | 0.99% |
| EDGEWISE THERAPEUTICS INC | EWTX | $361,768 | 0.97% |
| PALVELLA THERAPEUTICS INC | PVLA | $359,039 | 0.96% |
| CAPRICOR THERAPEUTICS INC | CAPR | $356,149 | 0.95% |
| VAXCYTE INC | PCVX | $354,945 | 0.95% |
| ARRIVENT BIOPHARMA INC | AVBP | $351,317 | 0.94% |
| XENON PHARMACEUTICALS INC | XENE | $351,035 | 0.94% |
| NEUROGENE INC | NGNE | $344,205 | 0.92% |
| SUMMIT THERAPEUTICS INC | SMMT | $337,094 | 0.90% |
| AMYLYX PHARMACEUTICALS INC | AMLX | $337,088 | 0.90% |
| CELLDEX THERAPEUTICS INC | CLDX | $329,852 | 0.88% |
| PRAXIS PRECISION MEDICINES INC | PRAX | $327,120 | 0.88% |
| ARCUS BIOSCIENCES INC | RCUS | $326,885 | 0.88% |
| ANNEXON INC | ANNX | $325,990 | 0.87% |
| TERNS PHARMACEUTICALS INC | 880881107 | $324,567 | 0.87% |
| LIQUIDIA CORP | LQDA | $324,188 | 0.87% |
| MONTE ROSA THERAPEUTICS INC | GLUE | $324,056 | 0.87% |
| IMMUNOME INC | IMNM | $323,500 | 0.87% |
| BICARA THERAPEUTICS INC | BCAX | $322,276 | 0.86% |
| CELCUITY INC | CELC | $318,058 | 0.85% |
| IRONWOOD PHARMACEUTICALS INC | IRWD | $318,025 | 0.85% |
| ABCELLERA BIOLOGICS INC | ABCL | $316,417 | 0.85% |
| PRECIGEN INC | PGEN | $311,164 | 0.83% |
| BELITE BIO INC | BLTE | $310,680 | 0.83% |
| BEAM THERAPEUTICS INC | BEAM | $305,939 | 0.82% |